Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

214.82
Delayed Data
As of Jan 23
 +0.48 / +0.22%
Today’s Change
184.50
Today|||52-Week Range
301.32
+2.29%
Year-to-Date
Why Cynosure, Inc. Is Rising Today
Jan 23 / MotleyFool.com - Paid Partner Content
Clear Harbor Asset Management, LLC Buys General Motors Co, Qorvo Inc, Toll Brothers I...
Jan 20 / GuruFocus News - Paid Partner Content
Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open
Jan 23 / TheStreet.com - Paid Partner Content
Jim Cramer Is No Fan of Retail Stocks in the Age of Amazon
Jan 20 / TheStreet.com - Paid Partner Content
Biotech School: When Cellceutix CEO Rants About 'Criminal' Short, Smart Investors See...
Jan 23 / TheStreet.com - Paid Partner Content
Synergy Pharmaceuticals Secures Approval for Linzess Competitor
Jan 20 / TheStreet.com - Paid Partner Content
How Will Pfizer Inc. Fare Under President Trump?
Jan 21 / MotleyFool.com - Paid Partner Content
Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.
Jan 20 / Zacks.com - Paid Partner Content
Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?
Jan 20 / Zacks.com - Paid Partner Content
Should Value Investors Choose Allergan (AGN)?
Jan 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close214.34
Today’s open212.43
Day’s range211.11 - 218.08
Volume3,877,584
Average volume (3 months)4,704,932
Market cap$80.4B
Dividend yield1.30%
Data as of 4:02pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-0.01%
Earnings growth (next 5 years)+11.50%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.77+1.56%
LLYEli Lilly and Co-0.49-0.64%
CELGCelgene-0.35-0.31%
ABTAbbott Laboratories-0.12-0.30%
Data as of 4:02pm ET, 01/23/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$3.75
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs